In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Journal of the Royal Statistical Society. Series A (Statistics in Society), Vol. 180, No. 4 (OCTOBER 2017), pp. 1191-1209 (19 pages) Area level models, such as the Fay–Herriot model, aim to improve ...

Functional safety engineers follow the ISA/IEC 61511 standard and perform calculations based on random hardware failures. These result in very low failure probabilities, which are then combined with ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

We consider the usual proportional hazards model in the case where the baseline hazard, the covariate link, and the covariate coefficients are all unknown. Both the baseline hazard and the covariate ...

Suggested Citation: "Appendix D: Using Bayes Analysis for Hypothesis Testing." National Academies of Sciences, Engineering, and Medicine. 2019. Reproducibility and ...

The FDA has released new draft guidance outlining the use of Bayesian methodologies in clinical trials for drugs and biologics. The guidance is intended to help sponsors apply modern statistical ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American I’m not sure when I first heard of Bayes’ ...

For the moment, monitoring threats using big-data technology complements traditional perimeter defences. But ultimately it will replace measures such as antivirus and firewalls, according the head of ...